[ Science 37 raises $29M in Series C ]
Science 37 has raised $29 million in Series C funding.
Founded in 2014, Science 37 takes a mobile-first approach to running clinical trials, as it works to more easily connect patients with scientists by eroding geographical barriers.
The company’s latest cash injection will be used to expand its platform and further recruitment efforts.
|City||Los Angeles, California|
|Founder / CEO||Noah Craft|
|Glynn Capital Management|
|Previous Investors||Sanofi-Genzyme BioVentures|